台灣臨床試驗主持人資料庫|TPIDB

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberCVAY736A2301E1

Active

2024-01-15 - 2031-06-30

Phase III

Recruiting4

ICD-10M35.00

Sicca syndrome, unspecified

ICD-10M35.01

Sicca syndrome with keratoconjunctivitis

ICD-10M35.09

Sicca syndrome with other organ involvement

ICD-9710.2

Sicca syndrome

Trial Applicant

NOVARTIS (TAIWAN) CO., LTD.
Sponsor
Trial scale

Multi-Regional Multi-Center
Update

2026/02/01

Investigators and Locations

Principal Investigator Yi-Ming Chen Division of Rheumatology

Taichung Veterans General Hospital

Co-Principal Investigator

HSIN-HUA CHEN Division of Rheumatology
賴國隆 Division of Rheumatology
陳彥如 Division of Rheumatology
謝佳偉 Division of Rheumatology
林靖才 Division of Rheumatology
廖育婉 Division of Rheumatology
吳沂達 Division of Rheumatology
WEN-NAN HUANG Division of Rheumatology
譚國棟 Division of Rheumatology

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 許鐘元 Division of Rheumatology

Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.

Co-Principal Investigator

蘇昱日 Division of Rheumatology
陳嘉夆 Division of Rheumatology

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 王愷君 Division of Rheumatology

Kaohsiung Veterans General Hosptial

Co-Principal Investigator

石孟潔 Division of Rheumatology
王立峰 Division of Rheumatology
曾瑞成 Division of Rheumatology

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Joung-Liang Lan Division of Rheumatology

China Medical University Hospital

Co-Principal Investigator

黃建中 Division of Rheumatology

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

Taiwan

12 participants
Global

600 participants